K791084

Substantially Equivalent

PLUS CHEM, DETERMINATION OF ALT (GPT)

Applicant: Smithkline Diagnostics, Inc.
Product code: CKA
Advisory panel: Clinical Chemistry
Date received: 1979-06-12
Decision date: 1979-07-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Walker, MI, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.